Key Events This Week
7 Sep: Stock opens at Rs.8,760, up 1.04% despite Sensex decline
9 Sep: Stock peaks at Rs.8,960, gaining 1.82% on strong volume
10 Sep: Minor correction to Rs.8,875 amid technical consolidation
11 Sep: Upgrade to Strong Buy rating announced; technical momentum shifts bullish
7 September: Positive Start Despite Broader Market Weakness
Apollo Hospitals began the week on a strong note, closing at Rs.8,760.00, up 1.04% from the previous close of Rs.8,670.00. This gain was notable given the Sensex declined 0.46% to 36,218.97 on the same day. The stock’s outperformance was supported by healthy volume of 14,104 shares, signalling early investor interest. The resilience against a falling benchmark index suggested underlying strength in the company’s fundamentals and market positioning.
8 September: Steady Gains Amid Continued Market Pressure
On 8 September, Apollo Hospitals extended its gains modestly, rising 0.46% to close at Rs.8,800.00. The Sensex continued its downward trend, slipping 0.21% to 36,144.32. Volume increased to 20,193 shares, indicating sustained buying interest. The stock’s steady advance amid a cautious market environment reflected confidence in its sector leadership and operational performance.
9 September: Strong Rally on Robust Volume
The stock’s most significant move came on 9 September, when it surged 1.82% to Rs.8,960.00, its weekly high. This rally occurred despite the Sensex falling 0.62% to 35,921.77, highlighting Apollo Hospitals’ relative strength. Volume peaked at 22,030 shares, underscoring strong demand. This price action coincided with growing anticipation of positive fundamental developments and technical momentum shifts.
10 September: Minor Pullback Amid Technical Consolidation
After the strong rally, Apollo Hospitals experienced a slight correction on 10 September, closing down 0.95% at Rs.8,875.00. The Sensex was nearly flat, down 0.03% at 35,912.77. Volume moderated to 17,173 shares. This pullback was consistent with short-term profit-taking and technical consolidation following the prior day’s gains, setting the stage for renewed momentum.
Momentum building strong! This Mid Cap from NBFC is on our MomentumNow radar. Other investors are catching on – will you join?
- - Building momentum strength
- - Investor interest growing
- - Limited time advantage
11 September: Upgrade to Strong Buy and Technical Momentum Shift
The week culminated with a significant upgrade by MarketsMOJO, elevating Apollo Hospitals from a Buy to a Strong Buy rating on 10 September 2026. This upgrade reflected robust fundamentals, including a high Return on Capital Employed (ROCE) of 17.13%, consistent net sales growth of 16.82% annually, and an operating profit growth of 23.85%. The company’s market capitalisation stood at ₹1,27,609 crores, representing 16.45% of the hospital sector’s market cap, underscoring its dominant position.
Despite a slight price dip of 0.28% to Rs.8,850.00 on 11 September, technical indicators showed a bullish shift. The technical grade moved from mildly bullish to bullish, supported by positive monthly MACD and Bollinger Bands, while daily moving averages confirmed upward momentum. The stock’s 52-week high is Rs.9,326.80, with recent trading near the upper range signalling resilience.
Institutional ownership remains strong at 65.44%, reflecting confidence from sophisticated investors. The stock’s year-to-date return of 26.02% far outpaces the Sensex’s negative 12.11%, highlighting its relative strength. The upgrade and technical momentum shift provide a compelling backdrop for the stock’s medium-term outlook.
Want to dive deeper on Apollo Hospitals Enterprise Ltd.? There's a real-time research report diving right into the fundamentals, valuations, peer comparison, financials, technicals and much more!
- - Real-time research report
- - Complete fundamental analysis
- - Peer comparison included
Weekly Price Performance: Apollo Hospitals vs Sensex
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-09-07 | Rs.8,760.00 | +1.04% | 36,218.97 | -0.46% |
| 2026-09-08 | Rs.8,800.00 | +0.46% | 36,144.32 | -0.21% |
| 2026-09-09 | Rs.8,960.00 | +1.82% | 35,921.77 | -0.62% |
| 2026-09-10 | Rs.8,875.00 | -0.95% | 35,912.77 | -0.03% |
| 2026-09-11 | Rs.8,850.00 | -0.28% | 35,773.24 | -0.39% |
Key Takeaways
Positive Signals: Apollo Hospitals demonstrated resilience and outperformance throughout the week, gaining 2.08% while the Sensex declined 1.68%. The upgrade to a Strong Buy rating reflects robust fundamentals, including strong ROCE, consistent sales and profit growth, and attractive valuation metrics. Technical indicators have shifted bullish, supported by positive monthly MACD, Bollinger Bands, and daily moving averages. Institutional ownership remains high at 65.44%, signalling strong market confidence.
Cautionary Notes: Despite the overall positive momentum, the stock experienced minor pullbacks on 10 and 11 September, indicating short-term consolidation. Weekly MACD and KST indicators remain mildly bearish, suggesting some volatility and profit-taking may persist before a sustained uptrend is confirmed. Price resistance near the 52-week high of Rs.9,326.80 remains a key level to watch.
Conclusion
Apollo Hospitals Enterprise Ltd’s performance this week highlights its ability to outperform a weakening broader market through a combination of strong fundamentals and improving technical momentum. The upgrade to a Strong Buy rating by MarketsMOJO, underpinned by excellent operational metrics and a bullish technical outlook, reinforces the stock’s leadership position in the hospital sector. While short-term consolidation may continue, the company’s dominant market share, consistent earnings growth, and robust institutional backing provide a solid foundation for future price appreciation. Investors should monitor technical indicators closely for confirmation of sustained momentum beyond current resistance levels.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
